| 标题 |
712 SBT6290, a systemically administered Nectin-4-directed TLR8 ImmunoTAC (TM) therapeutic, is a potent human myeloid cell agonist for the treatment of Nectin-4-expressing tumors |
| 网址 | |
| DOI | |
| 其它 |
期刊:Regular and young investigator award abstracts 作者:Heather Metz; Ty Brender; Brenda Stevens; Damion Winship; Jamie Brevik; et al 出版日期:2020-11-10 |
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)